Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 01, 2023

SELL
$1.44 - $2.19 $1,283 - $1,951
-891 Reduced 38.06%
1,450 $2,000
Q1 2023

Apr 28, 2023

SELL
$1.17 - $2.7 $370 - $855
-317 Reduced 11.93%
2,341 $4,000
Q4 2022

Jan 27, 2023

BUY
$2.38 - $3.55 $2,875 - $4,288
1,208 Added 83.31%
2,658 $7,000
Q1 2022

May 02, 2022

BUY
$4.66 - $7.66 $932 - $1,532
200 Added 16.0%
1,450 $7,000
Q4 2021

Jan 25, 2022

BUY
$6.82 - $17.8 $682 - $1,780
100 Added 8.7%
1,250 $10,000
Q3 2021

Oct 28, 2021

BUY
$13.62 - $19.48 $15,663 - $22,402
1,150 New
1,150 $17,000

Others Institutions Holding ATAI

About ATAI Life Sciences N.V.


  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $234M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.